Bibliography
- JONES PW, AQUSTI AG: Outcome and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J. (2006) 27:822-832.
- LAPPERRE TS, SNOECK-STROBAND JB, GOSMAN MM et al.: Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. (2004) 170:499-504.
- MAKE B, CASABURI R, LEIDY NK: Interpreting results from clinical trials: understanding minimal clinical important differences in COPD outcomes. COPD (2004) 2:1-5.
- VESTBO J: The TORCH (towards a revolution in COPD health) survival study protocol. Eur. Respir. J. (2004) 24:206-210.
- CALVERLEY PMA, PAUWELS RA, VESTBO J et al.: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 361:449-456.
- SZAFRANSKI W, RAMIREZ A, MENGA G et al.: Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur. Respir. J. (2003) 21:74-81.
- CALVERLEY PMA, BOONSAWAT W, CSEKE Z et al.: Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur. Respir. J. (2003) 22:912-919.
- RABE KF, BATEMAN ED, O’DONNELL DE et al.: Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2005) 366:563-571.
- GIEMBYCZ MA: An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease. Br. J. Clin. Pharmacol. (2006) 62:138-152.
- HAIMAN CA, STRAM DO, WILKENS LR et al.: Ethinic and racial differences in the smoking-rleated rsik of lung cancer. N. Engl. J. Med. (2006) 354:333-342.
- WINTON T, LIVINGSTON R, JOHNSON D et al.: Vinorelbine puls Cisplatin versus observation in resected non-small-cell lung cancer. N. Engl. J. Med. (2006) 352:2589-2597.
- SILKOFF PE, ERZURUM SC, LUNDBERG JO et al.: ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc. Am. Thorac. Soc. (2006) 3:131-145.
- KHARITONOV SA, BARNES PJ: Exhaled biomarker. Chest (2006) 130:1541-1546.
- BARST RJ, GALIÉ N, NAEIJE R et al.: Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur. Respir. J. (2006) 28:1195-1203.
- Symposia: pathogenesis and treatment of chronic thromboembolic pulmonary hypertension. Proc. Am. Thorac. Soc. (2006) 3:563-614.
Website
- www.ersnet.org European Respiratory Society.